1. Home
  2. Analysis
  3. Triazolam
  4. Dymista

Triazolam and Dymista drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Triazolam (triazolam) and Dymista (azelastine hydrochloride; fluticasone propionate). Common drug interactions include weight decreased among females and psychotic disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Triazolam and Dymista. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Triazolam?

Triazolam has active ingredients of triazolam. It is often used in insomnia. eHealthMe is studying from 5,838 Triazolam users. Check the latest studies of Triazolam.

What is Dymista?

Dymista has active ingredients of azelastine hydrochloride; fluticasone propionate. It is often used in allergies. eHealthMe is studying from 4,407 Dymista users. Check the latest studies of Dymista.

On Jul, 27, 2026

16 people who take Triazolam and Dymista together, and have interactions are studied.

Triazolam and Dymista drug interactions.

What are the common drug interactions of Triazolam and Dymista, by gender? *:

female:

  1. Weight decreased
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Chronic kidney disease
  8. Depression
  9. Emotional distress
  10. Pain

male:

  1. Psychotic disorder
  2. Stress
  3. Nausea (feeling of having an urge to vomit)
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Vomiting
  6. Weight decreased

What are the common drug interactions of Triazolam and Dymista, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Psychotic disorder
  2. Stress

60+:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Ear infection
  3. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  4. Lower respiratory tract infection
  5. Rash
  6. Weight decreased
  7. Weight fluctuation
  8. Upper respiratory tract infection

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 10 people, 62.50%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 25.00%
  3. Hiv Infection: 2 people, 12.50%
  4. Appetite - Increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Triazolam and Dymista?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Triazolam and Dymista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Triazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dymista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Triazolam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dymista and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on triazolam and azelastine hydrochloride; fluticasone propionate (the active ingredients of Triazolam and Dymista, respectively), and Triazolam and Dymista (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.